152 related articles for article (PubMed ID: 11071724)
1. US FDA Advisory Committee meetings held to discuss isotretinoin, safety issues and a new accutane formulation.
Maddin S
Skin Therapy Lett; 2000; 6(2):5. PubMed ID: 11071724
[No Abstract] [Full Text] [Related]
2. A review of the European Directive for prescribing systemic isotretinoin for acne vulgaris.
Layton AM; Dreno B; Gollnick HP; Zouboulis CC
J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):773-6. PubMed ID: 16898895
[TBL] [Abstract][Full Text] [Related]
3. The cost of clear skin: balancing the social and safety costs of iPLEDGE with the efficacy of Accutane (isotretinoin).
Doshi A
Seton Hall Law Rev; 2007; 37(2):625-60. PubMed ID: 17294569
[No Abstract] [Full Text] [Related]
4. Safety issues in isotretinoin therapy.
Hanson N; Leachman S
Semin Cutan Med Surg; 2001 Sep; 20(3):166-83. PubMed ID: 11594672
[TBL] [Abstract][Full Text] [Related]
5. Isotretinoin prescribing: finding a balance between benefit and risk.
Stern RS
Pharmacoepidemiol Drug Saf; 2005 Sep; 14(9):611-3. PubMed ID: 16134100
[No Abstract] [Full Text] [Related]
6. Accutane (isotretinoin) and psychiatric adverse effects.
Wooltorton E
CMAJ; 2003 Jan; 168(1):66. PubMed ID: 12515789
[No Abstract] [Full Text] [Related]
7. Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoin.
Strauss JS; Leyden JJ; Lucky AW; Lookingbill DP; Drake LA; Hanifin JM; Lowe NJ; Jones TM; Stewart DM; Jarratt MT; Katz I; Pariser DM; Pariser RJ; Tschen E; Chalker DK; Rafal ES; Savin RP; Roth HL; Chang LK; Baginski DJ; Kempers S; McLane J; Eberhardt D; Leach EE; Bryce G; Hong J
J Am Acad Dermatol; 2001 Aug; 45(2):196-207. PubMed ID: 11464180
[TBL] [Abstract][Full Text] [Related]
8. Family physicians and accutane.
Van Durme DJ
Am Fam Physician; 2000 Oct; 62(8):1772, 1774, 1777. PubMed ID: 11057835
[No Abstract] [Full Text] [Related]
9. Accutane risk management program strengthened.
FDA Consum; 2002; 36(1):8. PubMed ID: 11881607
[No Abstract] [Full Text] [Related]
10. Possible association between isotretinoin and inflammatory bowel disease.
Reddy D; Siegel CA; Sands BE; Kane S
Am J Gastroenterol; 2006 Jul; 101(7):1569-73. PubMed ID: 16863562
[TBL] [Abstract][Full Text] [Related]
11. Accutane-exposed pregnancies--California, 1999.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2000 Jan; 49(2):28-31. PubMed ID: 10680601
[TBL] [Abstract][Full Text] [Related]
12. Adolescents, acne, and the side-effects of Accutane.
Novotny J
Pediatr Nurs; 1989; 15(3):247-8. PubMed ID: 2525246
[TBL] [Abstract][Full Text] [Related]
13. How to ensure fetal safety when mothers use isotretinoin (Accutane).
Koren G; Pastuszak A
Can Fam Physician; 1997 Feb; 43():216-9. PubMed ID: 9040906
[No Abstract] [Full Text] [Related]
14. FDA, Roche to implement new dispensing procedures for isotretinoin.
Young D
Am J Health Syst Pharm; 2001 Dec; 58(24):2359-60. PubMed ID: 11794946
[No Abstract] [Full Text] [Related]
15. Safety and side effects of the acne drug, oral isotretinoin.
Charakida A; Mouser PE; Chu AC
Expert Opin Drug Saf; 2004 Mar; 3(2):119-29. PubMed ID: 15006718
[TBL] [Abstract][Full Text] [Related]
16. Is accutane really dangerous?
Med Lett Drugs Ther; 2002 Sep; 44(1139):82. PubMed ID: 12322695
[No Abstract] [Full Text] [Related]
17. Myths of isotretinoin therapy in patients with acne: a personal opinion.
Alcalay J
J Drugs Dermatol; 2004; 3(2):179-82. PubMed ID: 15098974
[TBL] [Abstract][Full Text] [Related]
18. The power of Accutane. The benefits and risks of a breakthrough acne drug.
Meadows M
FDA Consum; 2001; 35(2):18-23. PubMed ID: 11444244
[No Abstract] [Full Text] [Related]
19. Transgender Patients, Isotretinoin, and US Food and Drug Administration-Mandated Risk Evaluation and Mitigation Strategies: A Prescription for Inclusion.
Katz KA
JAMA Dermatol; 2016 May; 152(5):513-4. PubMed ID: 26762226
[No Abstract] [Full Text] [Related]
20. Adverse effects of isotretinoin therapy for acne vulgaris.
Lamb SR; Oakley AM
N Z Med J; 2001 Sep; 114(1139):414. PubMed ID: 11665936
[No Abstract] [Full Text] [Related]
[Next] [New Search]
